Quick Answer
Oscar Health, Inc. reported Cash and Equivalents of $2.77 billion for fiscal year 2025.
Oscar Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $2.77B | +81.7% |
| 2024 | $1.53B | -18.3% |
| 2023 | $1.87B | +20.0% |
| 2022 | $1.56B | +41.2% |
| 2021 | $1.10B | +33.6% |
| 2020 | $826.33M | +145.5% |
| 2019 | $336.64M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.15B | +78.2% | -17.3% |
| June 30, 2025 | $2.60B | +14.6% | +16.2% |
| March 31, 2025 | $2.24B | +0.3% | +46.4% |
| December 31, 2024 | $1.53B | -18.3% | +26.6% |
| September 30, 2024 | $1.21B | -13.8% | -46.8% |
| June 30, 2024 | $2.27B | -2.3% | +1.7% |
| March 31, 2024 | $2.23B | +5.7% | +19.3% |
| December 31, 2023 | $1.87B | +20.0% | +33.6% |
- Oscar Health, Inc. showed an increase of +81.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2025 period, Oscar Health, Inc.’s cash and equivalents has grown by 724.1% (from $336.64 million to $2.77 billion).
- The most recent figure is from Oscar Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: